Yoshiyama M, Roppolo J R, de Groat W C
Department of Pharmacology, School of Medicine, University of Pittsburgh, Pennsylvania.
J Pharmacol Exp Ther. 1993 May;265(2):844-50.
The i.v. administration of MK-801 (dizocilpine), a noncompetitive N-methyl-D-aspartate receptor antagonist, depresses reflex bladder contractions in the rat, suggesting that glutamatergic transmission may have an important role in the micturition reflex pathway. The site of action of MK-801 was analyzed in the present experiments by studying the effects of the drug in the following urethane-anesthetized preparations: 1) intact rats, 2) decerebrate rats, 3) chronic spinal rats with transection at the T6-T8 segment and 4) intact rats in which the drug was administered via an intrathecal (i.t.) catheter at the L6-S1 spinal cord segments. Reflex bladder activity was monitored by measuring intravesical pressure under isovolumetric conditions and during a cystometrogram where the bladder outlet was open and voiding occurred. MK-801 (0.001-3 mg/kg i.v.) administered to the intact rats produced a dose-dependent suppression of the amplitude of reflex bladder contractions recorded during a cystometrogram. The ED50 and dose to produce maximal inhibition were 0.36 mg/kg and 3 mg/kg i.v., respectively. Doses of 0.3 to 1 mg/kg i.v. doubled the volume threshold for inducing micturition and decreased by 80% the voided volume in the intact rats. In decerebrate rats, reflex bladder contractions were also inhibited by MK-801 (ED50 = 0.055 mg/kg i.v.); however, in chronic spinal animals, even large doses of MK-801 (3-30 mg/kg i.v.) did not inhibit reflex bladder activity. MK-801 (6-78 micrograms) administered i.t. in the intact rats produced a dose-dependent suppression of the amplitude of reflex bladder contractions (ED50 = 13 micrograms). These results suggest that the inhibition of micturition reflex by MK-801 is mediated at least in part by an action on the lumbosacral spinal cord and is dependent on an intact pathway between the brain and spinal cord.
非竞争性N-甲基-D-天冬氨酸受体拮抗剂MK-801(地佐环平)静脉注射可抑制大鼠膀胱反射性收缩,这表明谷氨酸能传递在排尿反射通路中可能起重要作用。在本实验中,通过研究该药物在以下乌拉坦麻醉制剂中的作用,分析了MK-801的作用部位:1)完整大鼠;2)去大脑大鼠;3)在T6 - T8节段横断的慢性脊髓大鼠;4)通过L6 - S1脊髓节段的鞘内(i.t.)导管给药的完整大鼠。通过在等容条件下以及膀胱出口开放且发生排尿的膀胱测压图期间测量膀胱内压来监测膀胱反射活动。给完整大鼠静脉注射MK-801(0.001 - 3 mg/kg)可在膀胱测压图期间对记录的膀胱反射性收缩幅度产生剂量依赖性抑制。ED50和产生最大抑制的剂量分别为0.36 mg/kg静脉注射和3 mg/kg静脉注射。0.3至1 mg/kg静脉注射剂量可使完整大鼠诱导排尿的体积阈值加倍,并使排尿量减少80%。在去大脑大鼠中,MK-801(ED50 = 0.055 mg/kg静脉注射)也可抑制膀胱反射性收缩;然而,在慢性脊髓动物中,即使大剂量的MK-801(3 - 30 mg/kg静脉注射)也不能抑制膀胱反射活动。在完整大鼠中鞘内注射MK-801(6 - 78微克)可对膀胱反射性收缩幅度产生剂量依赖性抑制(ED50 = 13微克)。这些结果表明,MK-801对排尿反射的抑制至少部分是通过对腰骶脊髓的作用介导的,并且依赖于脑和脊髓之间完整的通路。